Design
Review
Authors
Loading...
Endothelin-targeted therapies merit randomized trials in hypertension and HF; leaves open any role in current practice.
Key points are not available for this paper at this time.
Roy G. Goldie (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: